Healthcare (TRBC)
(Reuters) - Drug developer UniQure NV said on Friday its gene therapy to treat hemophilia B increased the levels of a protein that helps in [more…]
TOKYO (Reuters) - The Japanese subsidiary of Pfizer Inc is recalling a drug for high blood pressure which was found to contain a substance that [more…]
(Reuters Health) - Kids living with type 1 diabetes are no different from their peers in their reading and math test scores, a Danish study [more…]
(Reuters Health) - Surgery for shoulder pain that isn’t caused by an injury has no better results than nonsurgical options or placebo surgery, and comes [more…]
(Reuters Health) - Patients may have less access to palliative care at U.S. hospitals that primarily serve minorities, a study suggests. Minorities in the U.S. [more…]
(Reuters) - The U.S. Food and Drug Administration said on Thursday it was taking action against certain retailers including Walgreen Boots Alliance for repeatedly flouting [more…]
(Reuters) - Shares of U.S. gene therapy companies sank on Thursday after drugs developed by two small firms failed to show promise in separate clinical [more…]
CINCINNATI (Reuters) - When Danny Reagan was 13, he began exhibiting signs of what doctors usually associate with drug addiction. He became agitated, secretive and [more…]
GENEVA (Reuters) - Democratic Republic of Congo’s Ebola outbreak has spread southwards into an area with high security risks, the World Health Organization said. The [more…]
Medicare Part D no match for runaway specialty drug costs: study
Published 07/02/2019
CHICAGO (Reuters) - When Medicare prescription drug insurance was created in 2003, the idea that beneficiaries with very high drug costs should pick up 5 [more…]